Journal of Prevention and Treatment for Stomatological Diseases ›› 2019, Vol. 27 ›› Issue (3): 137-142.doi: 10.12016/j.issn.2096-1456.2019.03.001

• Expert Forum • Previous Articles     Next Articles

Abnormal glucose and lipid metabolism and oral squamous cell carcinoma

WANG Anxun()   

  1. Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
  • Received:2018-07-30 Revised:2018-11-08 Online:2019-03-20 Published:2019-03-20
  • Contact: Anxun WANG E-mail:anxunwang@yahoo.com

Abstract:

Epidemiological studies have shown that abnormal glucose and lipid metabolism is associated with a variety of malignant tumors, including oral squamous cell carcinoma. In this paper, the role of abnormal glucose and lipid metabolism, especially diabetes mellitus and obesity, in the occurrence and development of oral squamous cell carcinoma and its pathogenesis are reviewed based on the research results of our group and the literature. Hyperglycemia and insulinemia in diabetes mellitus are the main mechanisms that increase the risk of cancer. Our research shows that hyperglycemia can promote the proliferation, invasion and metastasis of tongue squamous cell carcinoma through the glycolytic enzyme M2 pyruvate kinase (PKM2) and hexokinase 2 (HK2). Hyperinsulinemia can promote the proliferation, invasion and metastasis of tongue squamous cell carcinoma by activating the insulin-like growth factor signal transduction system. Obese patients are often accompanied by increased serum adipokine Chemerin (Chem). Our study shows that serum Chem concentrations in obese patients with tongue cancer are significantly higher compared with nonobese patients. Chem can regulate the proliferation, invasion and migration of tongue squamous cell carcinoma cells through the SOD2-H2O2 signaling pathway. These results provide a basis for the prevention of oral squamous cell carcinoma, provide a new iqdea for the precise treatment of oral squamous cell carcinoma, and suggest that the treatment of oral squamous cell carcinoma should also actively treat patients with diabetes and obesity.

Key words: Diabetes mellitus, Obesity, Metabolic disease, Oral squamous cell carcinoma, Proliferation, Invasion, Glycose metabolism, Lipid metabolism

CLC Number: 

  • R739.8

Figure 1

Obesity, diabetes and oral squamous cell carcinoma[14,40]"

[1] Shield KD, Ferlay J, Jemal AA , et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012[J]. CA Cancer J Clin, 2017,67(1):51-64.
doi: 10.3322/caac.21384 pmid: 28076666
[2] Cho NH, Shaw JE, Karuranga S , et al. IDF diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract, 2018,138:271-281.
doi: 10.1016/j.diabres.2018.02.023 pmid: 29496507
[3] Yang W, Lu J, Weng J , et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010,362(12):1090-1101.
doi: 10.1056/NEJMoa0908292
[4] Wang M, Hu RY, Wu HB , et al. Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China[J]. Sci Rep, 2015,5:11503.
doi: 10.1038/srep11503
[5] He D, Bai JW, Liu J , et al. Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus[J]. Mol Clin Oncol , 2015,3(3):607-612.
doi: 10.3892/mco.2015.522 pmid: 26137275
[6] Giovannucci E, Harlan DM, Archer MC , et al. Diabetes and cancer: a consensus report[J]. CA Cancer J Clin, 2010,60(4):207-221.
doi: 10.3322/caac.20078
[7] Peairs KS, Barone BB, Snyder CF , et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis[J]. J Clin Oncol, 2011,29(1):40-46.
doi: 10.1200/JCO.2009.27.3011 pmid: 21115865
[8] Yuan C, Rubinson DA, Qian ZR , et al. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus[J]. J Clin Oncol, 2015,33(1):29-U58.
doi: 10.1200/JCO.2014.57.5688 pmid: 25403204
[9] Yuhara H, Steinmaus C, Cohen SE , et al. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?[J]. Am J Gastroenterol, 2011,106(11):1911-1921.
doi: 10.1038/ajg.2011.301 pmid: 3741453
[10] Joshi S, Liu MH, Turner N . Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime[J]. Biomed Res Int, 2015: 390863.
doi: 10.1155/2015/390863 pmid: 4413255
[11] Tseng CH . Metformin may reduce oral cancer risk in patients with type 2 diabetes[J]. Oncotarget, 2016,7(2):2000-2008.
doi: 10.18632/oncotarget.6626 pmid: 26683519
[12] Liu CJ, Chang WJ, Chen CY , et al. Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis[J]. Oncotarget, 2015,6(30):29268-29284.
doi: 10.1016/j.ijom.2015.08.674 pmid: 26337468
[13] Wu CH, Wu TY, Li CC , et al. Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: a retrospective cohort study[J]. Ann Surg Oncol, 2010,17(8):2175-2183.
doi: 10.1245/s10434-010-0996-1 pmid: 20224856
[14] Wang W, He QT, Yan WX , et al. High glucose enhances the metastatic potential of tongue squamous cell carcinoma via the PKM2 pathway[J]. Oncotarget, 2017,8(67):111770-111779.
doi: 10.18632/oncotarget.22907 pmid: 29340090
[15] Ahmad FS, Ning H, Rich JD , et al. Hypertension, obesity, diabetes, and heart failure-free survival: the cardiovascular disease lifetime risk pooling project[J]. JACC Heart Fail, 2016,4(12):911-919.
doi: 10.1016/j.jchf.2016.08.001
[16] Ewertz M, Gray KP, Regan MM , et al. Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial[J]. J Clin Oncol, 2012,30(32):3967-3975.
doi: 10.1200/JCO.2011.40.8666 pmid: 23045588
[17] Okabayashi K, Ashrafian H, Hasegawa H , et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2012,107(8):1175-1185, 1186.
doi: 10.1038/ajg.2012.180 pmid: 22733302
[18] Wu C, Wang L, Chen W , et al. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: a retrospective study[J]. Medicine (Baltimore), 2017,96(9):e6202.
doi: 10.1097/MD.0000000000006202 pmid: 28248875
[19] Study:obesity and survival in tongue cancer patients[J]. J Calif Dent Assoc, 2014,42(4):218.
pmid: 25080736
[20] Iyengar NM, Kochhar A, Morris PG , et al. Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue[J]. Cancer, 2014,120(7):983-991.
doi: 10.1002/cncr.28532 pmid: 24449483
[21] Pollak M . The insulin and insulin-like growth factor receptor family in neoplasia: an update[J]. Nat Rev Cancer, 2012,12(3):159-169.
doi: 10.1038/nrc3215 pmid: 22337149
[22] Lee SC, Chan JC . Evidence for DNA damage as a biological link between diabetes and cancer[J]. Chin Med J (Engl), 2015,128(11):1543-1548.
doi: 10.4103/0366-6999.157693 pmid: 4733759
[23] Duan WX, Shen X, Lei JJ , et al. Hyperglycemia, a neglected factor during cancer progression[J]. Biomed Res Int, 2014: 461917.
doi: 10.1155/2014/461917 pmid: 4016871
[24] Li JH, Ma JG, Han L , et al. Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer[J]. Cancer Biol Ther, 2015,16(6):912-921.
doi: 10.1080/15384047.2015.1040952 pmid: 25946624
[25] Li W, Zhang L, Chen X , et al. Hyperglycemia promotes the epithelial-mesenchymal transition of pancreatic cancer via hydrogen peroxide[J]. Oxid Med Cell Longev, 2016: 5190314.
doi: 10.1155/2016/5190314 pmid: 4940572
[26] Sandulache VC, Ow TJ, Pickering CR , et al. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells[J]. Cancer, 2011,117(13):2926-2938.
doi: 10.1002/cncr.v117.13
[27] Meijer TW, Kaanders JH, Span PN , et al. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy[J]. Clin Cancer Res, 2012,18(20):5585-5594.
doi: 10.1158/1078-0432.CCR-12-0858 pmid: 23071360
[28] Patra KC, Wang Q, Bhaskar PT , et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer[J]. Cancer Cell, 2013,24(2):213-228.
doi: 10.1016/j.ccr.2013.06.014 pmid: 23911236
[29] Wolf A, Agnihotri S, Micallef J , et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme[J]. J Exp Med, 2011,208(2):313-326.
doi: 10.1084/jem.20101470 pmid: 21242296
[30] Palmieri D, Fitzgerald D, Shreeve SM , et al. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis[J]. Mol Cancer Res, 2009,7(9):1438-1445.
doi: 10.1158/1541-7786.MCR-09-0234 pmid: 19723875
[31] Shuch B, Wm L, Srinivasan R . Aerobic glycolysis: a novel target in kidney cancer[J]. Expert Rev Anticancer Ther, 2013,13(6):711-719.
doi: 10.1586/era.13.57 pmid: 4165485
[32] Christofk HR, Vander Heiden MG, Harris MH , et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth[J]. Nature, 2008,452(7184):230-233.
doi: 10.1038/nature06734
[33] Liu WR, Tian MX, Yang LX , et al. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma[J]. Oncotarget, 2015,6(2):846-861.
doi: 10.18632/oncotarget.2749 pmid: 4359260
[34] Grimm M, Cetindis M, Lehmann M , et al. Association of cancer metabolism-related proteins with oral carcinogenesis-indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?[J]. J Transl Med, 2014,12:208.
doi: 10.1186/1479-5876-12-208 pmid: 4110933
[35] Wang W, Liu ZH, Zhao LD , et al. Hexokinase 2 enhances the metastatic potential of tongue squamous cell carcinoma via the SOD2-H2O2 pathway[J]. Oncotarget, 2017,8(2):3344-3354.
doi: 10.18632/oncotarget.13763 pmid: 27926482
[36] Wang W, He QT, Sun JJ , et al. Pyruvate kinase M2 deregulation enhances the metastatic potential of tongue squamous cell carcinoma[J]. Oncotarget, 2017,8(40):68252-68262.
doi: 10.18632/oncotarget.19291
[37] De-Freitas-Junior JCM, Andrade-Da-Costa J, Silva MC , et al. Glycans as regulatory elements of the insulin/IGF system: impact in cancer progression[J]. Int J Mol Sci, 2017,18(9):e1921.
doi: 10.3390/ijms18091921
[38] Alvarez-Nava F, Lanes R . GH/IGF-1 signaling and current knowledge of epigenetics; a review and considerations on possible therapeutic options[J]. Int J Mol Sci, 2017,18(10):e1624.
doi: 10.3390/ijms18101624 pmid: 28981462
[39] Sun JJ, Lu ZY, Deng Y , et al. Up-regulation of INSR/IGF1R by C-myc promotes TSCC tumorigenesis and metastasis through the NF-kappa B pathway[J]. Biochim Biophys Acta Mol Basis Dis, 2018,1864(5):1873-1882.
doi: 10.1016/j.bbadis.2018.03.004 pmid: 29518496
[40] Trayhurn P . Hypoxia and adipose tissue function and dysfunction in obesity[J]. Physiol Rev, 2013,93(1):1-21.
doi: 10.1152/physrev.00017.2012 pmid: 23303904
[41] Poloz Y, Stambolic V . Obesity and cancer. A case for insulin signaling[J]. Cell Death Dis, 2015,6(12):e2037.
doi: 10.1038/cddis.2015.381 pmid: 26720346
[42] Duan XF, Tang P, Li Q , et al. Obesity, adipokines and hepatocellular carcinoma[J]. Int J Cancer, 2013,133(8):1776-1783.
doi: 10.1002/ijc.28105 pmid: 23404222
[43] Deng T, Lyon CJ, Bergin S , et al. Obesity, inflammation, and cancer[J]. Annu Rev Pathol, 2016,11:421-449.
doi: 10.1146/annurev-pathol-012615-044359
[44] Martin R, Cordova C, Gutierrez B , et al. A dangerous liaison: leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells[J]. PLoS One, 2017,12(3):e170675.
doi: 10.1371/journal.pone.0170675 pmid: 28249041
[45] Hopkins BD, Goncalves MD, Cantley LC . Obesity and cancer mechanisms: cancer metabolism[J]. J Clin Oncol, 2016,34(35):4277.
doi: 10.1200/JCO.2016.67.9712 pmid: 27903152
[46] Toulany J, Parlee SD, Sinal CJ , et al. CMKLR1 activation ex vivo does not increase proportionally to serum total chemerin in obese humans[J]. Endocr Connect, 2016,5(6):70-81.
doi: 10.1530/EC-16-0065 pmid: 5148798
[47] Xu CH, Yang Y, Wang YC , et al. Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer[J]. Oncotarget, 2017,8(14):22483-22489.
doi: 10.18632/oncotarget.14956 pmid: 28160556
[48] Mariani F, Roncucci L . Chemerin/chemR23 axis in inflammation onset and resolution[J]. Inflamm Res, 2015,64(2):85-95.
doi: 10.1007/s00011-014-0792-7 pmid: 25548799
[49] Perumalsamy S, Zin NA, Widodo RT , et al. Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer[J]. Curr Pharm Des, 2017,23(25):3689-3698.
doi: 10.2174/1381612823666170616081256 pmid: 28625137
[50] Kumar JD, Kandola S, Tiszlavicz L , et al. The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells[J]. Br J Cancer, 2016,114(10):1152-1159.
doi: 10.1038/bjc.2016.93 pmid: 27092781
[1] ZHONG qijian,JIN Tingting,PENG Yu,CHEN Weixiong,LI Jinsong. The effect of silencing the endoplasmic reticulum stress-related protein calnexin on the proliferation, invasion, and migration of tongue squamous cell carcinoma cells [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(8): 535-540.
[2] WANG Qianqian,DING Dandan,DING Xiang,HAN Rui,HAN Yingying,ZHOU Meiyun,XU Jincheng. Expression of Bex1 and NF-kBp65 in tongue squamous cell carcinoma and its significance [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(6): 383-387.
[3] LI Ming,NAN Xinrong,YUAN Zhenying,TANG Zhangui. Accuracy analysis of MRI in the depth of invasion assessment of tongue squamous cell carcinoma [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(5): 322-327.
[4] WANG Min,JIANG Nan,ZHU Songsong. A novel biomimetic micro/nano hierarchical interface of titanium enhances adhesion, proliferation and osteogenic differentiation of bone marrow mesenchymal cells [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(4): 226-233.
[5] WANG Anxun. Detection and significance of immune function in oral mucosa-associated diseases [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(2): 73-80.
[6] GUO Zhichen,SAKENDEKE Jumatai,JIA Xinyu,HU Lulu,GONG Zhongcheng. Retrospective analysis of 59 patients with descending necrotizing mediastinitis from oral and maxillofacial space infection [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(2): 94-98.
[7] SHI Shaojie,LIU Xiangdong,SONG Yingliang. The effect of hypoglycemic drugs on bone metabolism and dental implantation in type 2 diabetes mellitus patients [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(2): 110-114.
[8] ZHANG Yameng,ZHANG Huiyuan,RUAN Shihong,CHEN Xiaochun,GAN Xueqi,YU Haiyang. The level of antimicrobial peptides in gingival crevicular fluid and its correlation with periodontal clinical indexes in elderly patients with type 2 diabetic periodontitis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(11): 746-751.
[9] XU Tengfei,CHEN Bin,AO Huizhi,SUN Weibin,WU WenLei. Effect of the antimicrobial photodynamic therapy in the treatment of periodontitis in type 2 diabetes mellitus: a systematic review and meta-analysis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(11): 752-760.
[10] CHEN Zhen,ZHANG Wenbo,PENG Xin. Research progress on the neck management of oral squamous cell carcinoma with clinically node-positive neck [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(11): 776-781.
[11] SUN Jingxuan,LI Yanping,PAN Shuang,HE Lina,SUN Xiangyu,ZHANG Shuang,NIU Yumei. Effects of graphene on the proliferation, migration and morphology of dental pulp stem cells [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(10): 656-662.
[12] WANG Guangchao,LIU Lijun,JIANG Weiwen. Significance of phosphoinositol metabolism by DNA methylation may contribute in oral leukoplakia carcinogenesis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(10): 677-683.
[13] WANG Liye,GAO Ying,TIAN Chun. Identification of potential genetic markers in prognosis of oral squamous cell carcinoma patients by bioinformatic analysis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(1): 27-33.
[14] MA Lingzhi,SHI Jiaozhuang,GE Wenbin,ZHANG Kun,YU Bing,LIU Yali. Effect of miR-21 on the proliferation and osteogenic differentiation of human periodontal ligament stem cells [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(9): 569-574.
[15] CAO Shunshun,WANG Xiaolong,SHU Chuanji,SHAO Jianjie. Inhibitory effect of celecoxib on Cal-27 tongue squamous cell carcinoma cell proliferation [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(7): 427-432.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] ZHU Song-song, HU Jing. The application of distraction osteogenesis in the temporomandibular joint ankylosis and secondary dentofacial deformities[J]. journal1, 2016, 24(1): 6 -10 .
[2] XU Jing. The influence of the impacted mandibular third molar extraction on the distal periodontal tissue of the mandibular second molar[J]. journal1, 2016, 24(1): 11 -14 .
[3] ZHONG Jiang-long, PAN Ji-yang, CHEN Wei-liang. The evaluation of Eagle syndrome treatment by surgery combined with antidepressant therapy[J]. journal1, 2016, 24(1): 26 -28 .
[4] CHEN Xi, SUN Qin-zhou. The study of colorimetric board of porcelain fused to metal restoration for moderate to severe dental fluorosis[J]. journal1, 2016, 24(1): 33 -36 .
[5] OUYANG Ke-xiong1, LIANG Jun, ZOU Rui, LI Zhi-qiang, BAI Zhi-bao, PIAO Zheng-guo, ZHAO Jian-Jiang.. Ion Torrent RNA-Seq detection and analysis of the long non-coding RNA in tongue squamous cell carcinoma[J]. journal1, 2016, 24(1): 15 -19 .
[6] YU Pei, XUE Jing, ZHANG Xiao-wei, ZHENG Cang-shang. The influence of the roughness of zirconia ceramic surface on microbial attachment[J]. journal1, 2016, 24(1): 20 -25 .
[7] LIU Fang. Clinical assessment of two fissure sealant techniques in children’s dental caries prevention[J]. journal1, 2016, 24(1): 44 -45 .
[8] . [J]. journal1, 2016, 24(1): 49 -52 .
[9] LU Jian-rong, BAN Hua-jie, WANG Dai-you, ZHOU Hui-hui, LONG Ru, QIN Shu-hua. Clinical observation of sternocleidomastoid muscle flaps combined with artificial biological membrane reparing the defects after parotidectomy[J]. journal1, 2016, 24(1): 29 -32 .
[10] LI Bin, HE Xiao-ning, GAO Yuan, HU Yu-ping. Clinical analysis of pain after two kinds of apical stop preparation[J]. journal1, 2016, 24(1): 40 -43 .
This work is licensed under a Creative Commons Attribution 3.0 License.